In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...